Perphenazine Tablets Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets
Available Strengths: 2 mg, 4 mg, 8 mg, 16 mg
Reference Brands: Trilafon®(US & EU)
Category:
Antipsychotropic Drugs
Perphenazine is a typical antipsychotic that works by blocking dopamine D2 receptors in the brain, helping to reduce psychotic symptoms such as hallucinations, delusions, and thought disorders. It is primarily used for the treatment of schizophrenia and other psychotic conditions. Additionally, it may be used in low doses to control severe nausea and vomiting.
Perphenazine Tablets is available in Oral Tablets
and strengths such as 2 mg, 4 mg, 8 mg, 16 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Perphenazine Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Perphenazine Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Perphenazine tablets are FDA-approved in the United States for the treatment of schizophrenia and for the control of severe nausea and vomiting. In the EU, their availability varies by country under national procedures, primarily indicated for psychotic disorders. Regulatory requirements include GMP compliance, detailed clinical data on extrapyramidal side effects, and clear psychiatric risk labeling. U.S. submissions must follow FDA labeling guidelines and include pharmacovigilance plans. EU applications may require harmonization with national formularies. To explore dossier-ready Perphenazine tablets, alternative formulations, and global suppliers, visit Pharmatradz.com — your trusted B2B pharma sourcing platform.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing